Clinical Trial Update: Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating ITI-007 as an adjunctive therapy to lithium or valproate for bipolar depression has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Depression

Drugs mentioned

• ITI-007

Snippet

Sponsor: Intra-Cellular Therapies, Inc. | Conditions: Bipolar Depression | Phase 3 | Status: COMPLETED | Results posted: 2023-05-17